Literature DB >> 17515020

Infection, depression, and immunity in women after coronary artery bypass: a pilot study of cognitive behavioral therapy.

Lynn V Doering1, Rebecca Cross, Donna Vredevoe, Otoniel Martinez-Maza, Marie J Cowan.   

Abstract

CONTEXT: Depression is common after coronary artery bypass graft (CABG) surgery, but little is known about its effect on post-CABG inflammation or infection or about the most effective treatment for post-CABG depression.
OBJECTIVES: (1) To determine ifpost-CABG depression is associated with increased infectious illness and (2) to test effects of cognitive behavioral therapy (CBT) on depressive symptoms, inflammatory biomarkers, and post-CABG infections in depressed post-CABG women.
DESIGN: Randomized, controlled trial.
SETTING: Two urban tertiary care centers. PATIENTS: Fifteen clinically depressed women in the first month after CABG, along with a comparison group of 37 non-depressed postCABG women, were studied. Inclusion criteria were: < or = 75 years old, English-speaking, undergoing first-time CABG, available for 6 months offollow-up, and without malignancy or autoimmune disorders. INTERVENTION: Eight weeks of individual home-based CBT. MAIN OUTCOME MEASURES: (1) Depressive symptoms measured by the Beck Depression Inventory, (2) natural killer cell cytotoxicity (NKCC) measured by 51Cr-release assay, (3) infectious illness episodes measured by the Modified Health Review, (4) interleukin (IL)-6 and C reactive protein (CRP) measured by enzyme immunoabsorbent assay.
RESULTS: Clinically depressed post-CABG women exhibited decreased NKCC and a higher incidence of in-hospital fevers and infectious illness in the first 6 months after CABG. Among depressed women, CBT yielded moderate to large effects for improved NKCC (D=0.67) and decreased IL-6 (D=0.61), CRP (D=0.85), and postoperative infectious illnesses (D=0.93). CBT holds promise for improving depression and immunity and reducing infection and inflammation after CABG.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17515020

Source DB:  PubMed          Journal:  Altern Ther Health Med        ISSN: 1078-6791            Impact factor:   1.305


  24 in total

1.  Inflammatory markers and chronic exposure to fluoxetine, divalproex, and placebo in intermittent explosive disorder.

Authors:  Emil F Coccaro; Royce Lee; Elizabeth C Breen; Michael R Irwin
Journal:  Psychiatry Res       Date:  2015-07-29       Impact factor: 3.222

2.  Psychosocial Interventions and Immune System Function: A Systematic Review and Meta-analysis of Randomized Clinical Trials.

Authors:  Grant S Shields; Chandler M Spahr; George M Slavich
Journal:  JAMA Psychiatry       Date:  2020-10-01       Impact factor: 21.596

Review 3.  Effectiveness of Stress-Reducing Interventions on the Response to Challenges to the Immune System: A Meta-Analytic Review.

Authors:  Lemmy Schakel; Dieuwke S Veldhuijzen; Paige I Crompvoets; Jos A Bosch; Sheldon Cohen; Henriët van Middendorp; Simone A Joosten; Tom H M Ottenhoff; Leo G Visser; Andrea W M Evers
Journal:  Psychother Psychosom       Date:  2019-08-06       Impact factor: 17.659

4.  The effect of mindfulness meditation training on biological acute stress responses in generalized anxiety disorder.

Authors:  Elizabeth A Hoge; Eric Bui; Sophie A Palitz; Noah R Schwarz; Maryann E Owens; Jennifer M Johnston; Mark H Pollack; Naomi M Simon
Journal:  Psychiatry Res       Date:  2017-01-26       Impact factor: 3.222

Review 5.  Inflammation, sanitation, and consternation: loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression.

Authors:  Charles L Raison; Christopher A Lowry; Graham A W Rook
Journal:  Arch Gen Psychiatry       Date:  2010-12

6.  Mind-Body Medicine and Immune System Outcomes: A Systematic Review.

Authors:  Helané Wahbeh; Ashley Haywood; Karen Kaufman; Heather Zwickey
Journal:  Open Complement Med J       Date:  2009

7.  Prospective, multicenter study of ventricular assist device infections.

Authors:  Rachel J Gordon; Alan D Weinberg; Francis D Pagani; Mark S Slaughter; Pat S Pappas; Yoshifumi Naka; Daniel J Goldstein; Walter P Dembitsky; Julie C Giacalone; Jennifer Ferrante; Deborah D Ascheim; Alan J Moskowitz; Eric A Rose; Annetine C Gelijns; Franklin D Lowy
Journal:  Circulation       Date:  2013-01-11       Impact factor: 29.690

8.  Depressive symptoms and heart failure: examining the sociodemographic variables.

Authors:  Linda M Rohyans; Susan J Pressler
Journal:  Clin Nurse Spec       Date:  2009 May-Jun       Impact factor: 1.067

9.  Depressive symptoms and the risk of atherosclerotic progression among patients with coronary artery bypass grafts.

Authors:  Gregory A Wellenius; Kenneth J Mukamal; Ambar Kulshreshtha; Sharon Asonganyi; Murray A Mittleman
Journal:  Circulation       Date:  2008-04-21       Impact factor: 29.690

10.  Negative emotions and quality of life six months after cardiac surgery: the dominant role of depression not anxiety symptoms.

Authors:  Phillip J Tully; Robert A Baker; Deborah A Turnbull; Helen R Winefield; John L Knight
Journal:  J Behav Med       Date:  2009-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.